Singapore markets closed
Straits Times Index
3,101.93 +9.82 (+0.32%) Nikkei
28,029.57 +276.20 (+1.00%) Hang Seng
23,766.69 -22.24 (-0.09%) FTSE 100
7,122.32 -6.89 (-0.10%) BTC-USD
54,209.49 -2,517.10 (-4.44%) CMC Crypto 200
1,369.99 -71.77 (-4.98%)
Adamis Pharmaceuticals Corporation (ADMP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:47PM EST. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 111.66M |
| Enterprise value | 83.71M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 5.49 |
| Price/book (mrq) | 3.24 |
| Enterprise value/revenue | 4.70 |
| Enterprise value/EBITDA | -1.70 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.28 |
| 52-week change 3 | 52.08% |
| S&P500 52-week change 3 | 23.73% |
| 52-week high 3 | 2.3400 |
| 52-week low 3 | 0.4700 |
| 50-day moving average 3 | 1.0026 |
| 200-day moving average 3 | 0.9812 |
Share statistics
| Avg vol (3-month) 3 | 6.2M |
| Avg vol (10-day) 3 | 3.17M |
| Shares outstanding 5 | 148.89M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 147.89M |
| % held by insiders 1 | 1.06% |
| % held by institutions 1 | 10.16% |
| Shares short (14 Nov 2021) 4 | 11.94M |
| Short ratio (14 Nov 2021) 4 | 0.92 |
| Short % of float (14 Nov 2021) 4 | 8.06% |
| Short % of shares outstanding (14 Nov 2021) 4 | 8.02% |
| Shares short (prior month 14 Oct 2021) 4 | 9.61M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:17 |
| Last split date 3 | 12 Dec 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 29 Sep 2021 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -228.83% |
Management effectiveness
| Return on assets (ttm) | -57.21% |
| Return on equity (ttm) | -168.76% |
Income statement
| Revenue (ttm) | 17.8M |
| Revenue per share (ttm) | 0.14 |
| Quarterly revenue growth (yoy) | -12.50% |
| Gross profit (ttm) | 1.63M |
| EBITDA | -37.85M |
| Net income avi to common (ttm) | -52.2M |
| Diluted EPS (ttm) | -0.4210 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 28.73M |
| Total cash per share (mrq) | 0.19 |
| Total debt (mrq) | 775.75k |
| Total debt/equity (mrq) | 2.25 |
| Current ratio (mrq) | 4.56 |
| Book value per share (mrq) | 0.23 |
Cash flow statement
| Operating cash flow (ttm) | -36.55M |
| Levered free cash flow (ttm) | -28.99M |
© 2021 Yahoo. All rights reserved.
